Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rolf Gedeborg, Lars Lindhagen, Stacy Loeb, Johan Styrke, Hans Garmo & Pär Stattin. (2022) Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer. Scandinavian Journal of Urology 56:2, pages 104-111.
Read now
Read now
Articles from other publishers (5)
Rolf Gedeborg, Stacy Loeb, Johan Styrke, Ritva Kiiski‐Berggren, Hans Garmo & Pär Stattin. (2022)
Susceptibility to
SARS‐Cov
‐2 infection and risk for severe
COVID
‐19 in patients with prostate cancer on androgen deprivation therapy
. International Journal of Cancer 151:11, pages 1925-1934.
Crossref
Crossref
Renée Hogenhout, Ivo I. de Vos, Sebastiaan Remmers, Lionne D.F. Venderbos, Martijn B. Busstra & Monique J. Roobol. (2022) Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam. European Urology Open Science 42, pages 42-49.
Crossref
Crossref
Yong Ruan, Houqiang Xu & Xinqin Ji. (2022) High expression of NPM1 via the Wnt/β‐catenin signalling pathway might predict poor prognosis for patients with prostate adenocarcinoma. Clinical and Experimental Pharmacology and Physiology 49:4, pages 525-535.
Crossref
Crossref
Kristen Haase, Ines B. Menjak & Martine Puts. 2022. Frailty in Older Adults with Cancer. Frailty in Older Adults with Cancer
3
25
.
Rolf Gedeborg, Johan Styrke, Stacy Loeb, Hans Garmo & Pär Stattin. (2021) Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic. PLOS ONE 16:10, pages e0255966.
Crossref
Crossref